Phase separation-based screening identifies arsenic trioxide as the N-Myc-DNA interaction inhibitor for neuroblastoma therapy

Cancer Lett. 2025 Mar 1:612:217449. doi: 10.1016/j.canlet.2025.217449. Epub 2025 Jan 11.
No abstract available